Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Post by Canada2016on Jun 15, 2021 3:48am
257 Views
Post# 33386799

Be NICE !

Be NICE !So doing a little research and discovered what is called the NICE device. It works in mice and doesn't require immunosuppressive drugs. Study released in June. So we have been sitting on 32 million doing what appears nothing as people catch and pass us. When we could have announced work on the conformal coating. What will they announce at the AGM that they are going to be going to work with it and there will be a flow of NRs. Is that not what they said in January and it's 6 months after the fact. What company owns this NICE device ? Or are they new ? Maybe copied the idea. What is going on with the collabs like seriously a buyout of a bill or two is better then being worthless in the end. And you allow Dom to walk out the door better be because a buyout because he was one of the bright spots of the company. Allowed investor communication. Even in the study they jab Sernova by saying immunosuppressive drugs can result in infections. Comn the good doctor dr T mr T you going to lie down and cost yourself millions or you going to grind your d**k off and help us cross the finish line and make yourself Billions. Let's f**caking go !
<< Previous
Bullboard Posts
Next >>